as on December 13, 2025 at 2:29 am IST
Day's High
8.08%
Upside
52 Week's Low
52 Week's High
82.89%
Downside
8.07%
Upside
Check Quince Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$245.0M
EPS (TTM)
-1.0775
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-41.7M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-247.78%
Compare market cap, revenue, PE, and other key metrics of Quince Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $245.0M | NA | NA | 0.00% | ||
| BUY | $42.0B | 393.88% | -16.34 | -264.83% | |
| BUY | $54.5B | 206.63% | 1422.86 | 1.36% | |
| BUY | $114.3B | 101.65% | 31.25 | 31.35% | |
| BUY | $79.2B | 54.51% | 17.42 | 32.13% |
The Quince Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Quince Therapeutics Inc investment value today
Current value as on today
₹2,14,151
Returns
₹1,14,151
(+114.15%)
Returns from Quince Therapeutics Inc Stock
₹1,07,389 (+107.39%)
Dollar Returns*
₹6,762 (+6.76%)
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Quince Therapeutics Inc. Average target price of $7.5
Get share price movements and forecasts by analysts on Quince Therapeutics Inc.
What analysts predicted
43.87%UPSIDE
Target Price
$7.5
Current Price
$4.21
Analyzed by
6 Analysts
Target
$7.50
Quince Therapeutics Inc target price $7.5, a slight upside of 43.87% compared to current price of $4.21. According to 6 analysts rating.
Search interest for Quince Therapeutics Inc Stock has increased by 204% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:204% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, QNCX stock has moved up by 151.2%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 175.0% return, outperforming this stock by 67.1%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 885.5% return, outperforming this stock by 362.3%
| Organisation | Quince Therapeutics Inc |
| Headquarters | 611 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Healthcare |
| CEO | Dr. Dirk Thye M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Pamela M. Williamson FRAPS, M.B.A., RAC | Head of Regulatory Affairs |
Dr. Dirk Thye M.D. | CEO, Chief Medical Officer & Director |
Dr. Charles S. Ryan J.D., Ph.D. | President |
Mr. Brendan Hannah M.B.A. | Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer |
Mr. Giovanni Mambrini M.Sc. | Chief Technology Officer |
Ms. Mary Ellen Sillivos | Vice President of Human Resources |
Dr. Guenter R. Janhofer M.D., Ph.D. | Chief Scientific Officer |
Ms. Stacy Roughan | Vice President of Corporate Communications & Investor Relations |
Dr. Stewart A. Low Ph.D. | Head of Discovery |
Quince Therapeutics Inc share price today is $4.21 as on at the close of the market. Quince Therapeutics Inc share today touched a day high of $4.55 and a low of $4.21.
Quince Therapeutics Inc share touched a 52 week high of $4.55 on and a 52 week low of $0.72 on . Quince Therapeutics Inc stock price today i.e. is closed at $4.21,which is 7.47% down from its 52 week high and 484.48% up from its 52 week low.
Quince Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Quince Therapeutics Inc (QNCX) shares with as little as ₹90.544 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.44 in Quince Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Quince Therapeutics Inc share’s latest price of $4.21 as on December 13, 2025 at 2:29 am IST, you will get 2.3753 shares of Quince Therapeutics Inc. Learn more about
fractional shares .